Cantab Biopharmaceuticals

About:

Cantab Biopharmaceuticals engages in the discovery and development of innovative drugs and drug formulations.

Website: http://www.cantabbio.com

Top Investors: Celtic Pharma

Description:

Cantab Biopharmaceuticals Ltd is a drug development company focused on the development of "biosuperior" products. Based on Cambridge Science Park, Cantab is at the heart of the largest biotech cluster in Europe. Cantab is using it's extensive experience in biopharmaceutical discovery, process development and GMP manufacturing to expedite the development of biosuperiors from inception through clinical development. Previously marketed, off-patent, biologics will be enhanced by the application of appropriate cutting-edge technologies in protein expression/engineering, process/manufacturing technology, protein conjugation, formulation and drug delivery. Particular areas of drug characteristics that Cantab seek to improve upon are product presentation and stability, pharmacokinetics, pharmacodynamics, immunogenicity and drug delivery.

Total Funding Amount:

$8.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2006-01-01

Contact Email:

info(AT)cantabbio.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2010-01-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai